NasdaqCM - Delayed Quote USD

Ensysce Biosciences, Inc. (ENSC)

2.0800
+0.0300
+(1.46%)
At close: 4:00:00 PM EDT
2.1000
+0.02
+(0.96%)
After hours: 5:17:26 PM EDT
Currency in USD All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
6,730.1340
6,730.1340
10,718.1870
24,222.0950
19,870.4310
Operating Income
-6,730.1340
-6,730.1340
-10,718.1870
-24,222.0950
-19,870.4310
Net Non Operating Interest Income Expense
-1,290.4440
-1,290.4440
-353.9450
-4,984.6360
-5,080.8680
Other Income Expense
33.5690
33.5690
445.8570
4,999.0460
-4,194.6020
Pretax Income
-7,987.0090
-7,987.0090
-10,626.2750
-24,207.6850
-29,145.9010
Net Income Common Stockholders
-7,987.2250
-7,987.2250
-10,626.0110
-25,085.4960
-29,886.8510
Diluted NI Available to Com Stockholders
-7,987.2250
-7,987.2250
-10,626.0110
-25,085.4960
-29,886.8510
Basic EPS
-11.45
--
-70.40
-2.09k
-5.33k
Diluted EPS
-11.45
--
-70.40
-2.09k
-5.33k
Basic Average Shares
697.6860
--
150.9370
35.6330
5.6090
Diluted Average Shares
697.6860
--
150.9370
35.6330
5.6090
Total Operating Income as Reported
-6,730.1340
-6,730.1340
-10,718.1870
-24,222.0950
-19,870.4310
Total Expenses
6,730.1340
6,730.1340
10,718.1870
24,222.0950
19,870.4310
Net Income from Continuing & Discontinued Operation
-7,986.9350
-7,986.9350
-10,613.0740
-24,172.2920
-29,083.7110
Normalized Income
-7,986.9350
-7,986.9350
-10,613.0740
-24,172.2920
-26,763.9650
Interest Expense
1,290.4440
1,290.4440
353.9450
109.5250
1,295.3070
Net Interest Income
-1,290.4440
-1,290.4440
-353.9450
-4,984.6360
-5,080.8680
EBIT
-6,696.5650
-6,696.5650
-10,272.3300
-24,098.1600
-27,850.5940
EBITDA
-6,696.5650
-6,696.5650
-10,272.3300
-24,098.1600
-27,850.4430
Reconciled Depreciation
--
--
--
0
0.1510
Net Income from Continuing Operation Net Minority Interest
-7,986.9350
-7,986.9350
-10,613.0740
-24,172.2920
-29,083.7110
Total Unusual Items Excluding Goodwill
--
--
430.4370
5,756.7870
-2,319.7460
Total Unusual Items
--
--
430.4370
5,756.7870
-2,319.7460
Normalized EBITDA
-6,696.5650
-6,696.5650
-10,272.3300
-24,098.1600
-25,530.6970
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 3/14/2018

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

PALI Palisade Bio, Inc.
0.7649
-1.66%
 
TVGN Tevogen Bio Holdings Inc.
1.0900
+4.81%
 
DRMA Dermata Therapeutics, Inc.
0.8100
-7.25%
 
SPRC SciSparc Ltd.
0.3500
+12.90%
 
QNRX Quoin Pharmaceuticals, Ltd.
6.26
+0.36%
 
ZVSA ZyVersa Therapeutics, Inc.
0.5712
-16.59%
 
PHIO Phio Pharmaceuticals Corp.
1.8000
-11.76%
 
SXTP 60 Degrees Pharmaceuticals, Inc.
2.2600
-1.74%
 
PXMD PaxMedica, Inc.
0.0001
0.00%
 
CERO CERo Therapeutics Holdings, Inc.
0.7299
+4.27%